Clinical Trials Logo

Clinical Trial Summary

The purpose of this trial is to investigate whether a therapist-guided Internet-delivered cognitive behaviour therapy (ICBT) programme is feasible for adolescents with body dysmorphic disorder (BDD). The aim is to evaluate feasibility and provide preliminary efficacy data.


Clinical Trial Description

Rationale for study: BDD is a prevalent and impairing condition that can be effectively treated with cognitive-behaviour therapy (CBT). However, CBT for BDD is a highly specialised treatment and a majority of adolescents do not have access to it. ICBT can be a way to increase the availability of effective psychological treatments. No study to date has evaluated the feasibility of ICBT for adolescent BDD, but the experience in adults with BDD treated with ICBT is encouraging. Objectives: To investigate whether a therapist-guided Internet-delivered cognitive behaviour therapy (ICBT) programme is feasible for adolescents with body dysmorphic disorder (BDD). Specifically, the aim is to:(a) establish participant retention, ease of recruitment, acceptability, credibility, and satisfaction, (b) evaluate potential adverse events, and (c) provide preliminary efficacy data. Trial design and methods: Participants will be recruited nationally and will be offered 12 modules of ICBT for BDD, delivered over a period of 14 weeks. Participants will be assessed before, during, and after treatment, and up to 12 months after the end of the treatment. ICBT non-responders, assessed at post-treatment and one-, two-, and three-months after completing treatment, will be offered CBT delivered via video format (at post-treatment and after the 1MFU and the 2MFU) or traditional face-to-face (F2F) CBT at the OCD and Related Disorders Clinic for Children and Adolescents in Stockholm (after the 3MFU). The primary outcome is feasibility, as measured by examining rates of participant retention, treatment completion and adherence to treatment content, treatment acceptability, treatment credibility, treatment satisfaction and adverse events during the treatment. Secondary outcomes include improvement in clinician-reported BDD symptoms, as well as improvement in other clinical measures assessing disorder severity, disorder improvement, self-reported BDD symptoms, depressive symptoms, and functional impairment. Sample: 20 adolescents and their primary caregivers. Statistical analysis: Retention, acceptability, credibility, and treatment satisfaction. For retention and acceptability, information on ease of recruitment, number of completed modules, and attrition rates will collected and presented in a descriptive manner. Results from a credibility scale will be summarized in group means and standard deviations. Results from a treatment satisfaction scale will be summarized in group means and standard deviation. Potential adverse events: Type and impact of all potential adverse events will be measured with a specific scale and presented descriptively. Preliminary efficacy: Clinical measures of treatment outcomes will be measured via clinician-reported and self- and parent-reported measures and analysed through linear mixed models to detect within group change over time. Within-group effect sizes will be estimated with Cohen's d. Treatment response: The proportion of treatment responders will be calculated. Treatment response will be defined as a ≥30% reduction on the BDD-YBOCS-A, respective to the baseline score. Further, the investigators will also calculate how many participants are on full or partial symptom remission, defined as a score ⩽16 on the BDD-YBOCS-A. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05078320
Study type Interventional
Source Karolinska Institutet
Contact
Status Completed
Phase N/A
Start date October 22, 2021
Completion date June 26, 2023

See also
  Status Clinical Trial Phase
Completed NCT02524301 - Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study N/A
Recruiting NCT03918577 - Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders N/A
Completed NCT01398904 - Attentional Bias in Body Dysmorphic Disorder N/A
Completed NCT03773549 - A Virtual Reality Study of Cognitive Biases in Body Dysmorphic Disorder
Recruiting NCT05607121 - TMS Visual Modulation in Body Dysmorphic Disorder N/A
Completed NCT03221738 - Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder N/A
Completed NCT04254575 - Understanding Daily Changes in BDD Risk Using Smartphones
Completed NCT04103606 - A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Features in Female University Students N/A
Recruiting NCT01093950 - White Light Scanning to Aid Body Contouring: A Pilot Project N/A
Recruiting NCT04899687 - Study of Dextromethorphan in OCD and Related Disorders Phase 2
Completed NCT05612425 - Text Message Safety Behavior Fading for Appearance Concerns N/A
Completed NCT06370559 - Relationship Between Repetitive Negative Thinking and CBT Outcomes
Completed NCT04656301 - Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder Phase 2
Recruiting NCT06262412 - Internet-delivered Cognitive-behaviour Therapy for Child and Adolescent Body Dysmorphic Disorder N/A
Active, not recruiting NCT04034693 - Waitlist-Control Trial of Smartphone CBT for Body Dysmorphic Disorder (BDD) N/A
Recruiting NCT06346301 - Imagery Rescripting as a Stand-alone Treatment for OCD and BDD. N/A
Recruiting NCT01316627 - Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions Phase 2
Completed NCT03517384 - Feasibility Pilot Study of Internet-based Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder With Global Recruitment N/A